In this edition:
- Wearable devices may help detect AF
- Polypill strategy for secondary prevention
- Rivaroxaban vs VKA in patients with rheumatic heart disease and AF
- Mortality in patients with recent acute MI receiving antithrombotic therapy
- Aspirin for primary prevention in relation to lipoprotein(a) genotypes
- Early rhythm control for AF
- Morning vs evening dosing of antihypertensives
- Up-titration of guideline-directed medical therapies for acute HF
- Comparative efficacy and safety of DOACs in patients with AF
- BP lowering and prevention of dementia
Download the Cardiology Research Review: Issue 147, with commentary by A/Prof John Amerena (pdf)